Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)
China
· Delayed Price · Currency is CNY 25.28
-0.02 (-0.08%)
Apr 29, 2026, 3:00 PM CST
SHA:600196 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 62,516 | 65,095 | 59,749 | 61,592 | 86,922 | 113,862 | Upgrade
|
| Market Cap Growth | 4.17% | 8.95% | -2.99% | -29.14% | -23.66% | -9.48% | Upgrade
|
| Enterprise Value | 101,278 | 101,098 | 90,784 | 89,228 | 110,109 | 134,998 | Upgrade
|
| Last Close Price | 25.30 | 26.49 | 24.56 | 24.46 | 33.95 | 46.54 | Upgrade
|
| PE Ratio | 19.32 | 19.31 | 21.57 | 25.82 | 23.30 | 24.08 | Upgrade
|
| Forward PE | 20.57 | - | 21.15 | 21.49 | 19.36 | 20.43 | Upgrade
|
| PS Ratio | 1.48 | 1.56 | 1.46 | 1.49 | 1.98 | 2.92 | Upgrade
|
| PB Ratio | 0.98 | 1.05 | 1.00 | 1.09 | 1.61 | 2.35 | Upgrade
|
| P/TBV Ratio | 2.58 | 2.72 | 2.73 | 2.89 | 3.99 | 5.83 | Upgrade
|
| P/FCF Ratio | 70.65 | 85.12 | 894.58 | - | - | - | Upgrade
|
| P/OCF Ratio | 11.78 | 12.49 | 13.35 | 18.04 | 20.61 | 28.92 | Upgrade
|
| PEG Ratio | - | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | Upgrade
|
| EV/Sales Ratio | 2.39 | 2.43 | 2.21 | 2.15 | 2.51 | 3.46 | Upgrade
|
| EV/EBITDA Ratio | 15.47 | 17.18 | 16.34 | 22.98 | 19.87 | 32.27 | Upgrade
|
| EV/EBIT Ratio | 34.25 | 36.23 | 30.53 | 75.34 | 32.19 | 53.22 | Upgrade
|
| EV/FCF Ratio | 114.45 | 132.19 | 1359.25 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.62 | 0.59 | 0.60 | 0.62 | 0.56 | 0.53 | Upgrade
|
| Debt / EBITDA Ratio | 6.04 | 5.83 | 6.03 | 8.44 | 5.25 | 5.86 | Upgrade
|
| Debt / FCF Ratio | 44.67 | 47.63 | 539.31 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.38 | 0.34 | 0.33 | 0.34 | 0.24 | 0.23 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.93 | 3.58 | 3.58 | 5.01 | 2.35 | 2.60 | Upgrade
|
| Net Debt / FCF Ratio | 27.39 | 27.55 | 297.96 | -10.12 | -7.79 | -10.53 | Upgrade
|
| Asset Turnover | 0.35 | 0.35 | 0.36 | 0.38 | 0.44 | 0.44 | Upgrade
|
| Inventory Turnover | 3.27 | 3.09 | 2.90 | 3.01 | 3.77 | 3.82 | Upgrade
|
| Quick Ratio | 0.71 | 0.72 | 0.68 | 0.73 | 0.78 | 0.75 | Upgrade
|
| Current Ratio | 0.93 | 0.93 | 0.92 | 1.00 | 1.06 | 1.04 | Upgrade
|
| Return on Equity (ROE) | 7.04% | 6.98% | 6.03% | 5.23% | 7.70% | 10.55% | Upgrade
|
| Return on Assets (ROA) | 1.53% | 1.47% | 1.61% | 0.67% | 2.13% | 1.79% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.96% | 2.85% | 3.21% | 1.47% | 4.67% | 3.56% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.40% | 3.30% | 3.70% | 1.50% | 4.60% | 4.00% | Upgrade
|
| Earnings Yield | 5.56% | 5.18% | 4.64% | 3.87% | 4.29% | 4.15% | Upgrade
|
| FCF Yield | 1.42% | 1.18% | 0.11% | -3.12% | -1.92% | -0.91% | Upgrade
|
| Dividend Yield | 1.54% | 1.47% | 1.30% | 1.10% | 1.24% | 1.20% | Upgrade
|
| Payout Ratio | 62.45% | 66.18% | 86.45% | 102.89% | 63.64% | 40.48% | Upgrade
|
| Buyback Yield / Dilution | 0.76% | 0.90% | -0.02% | -2.40% | -1.74% | - | Upgrade
|
| Total Shareholder Return | 2.29% | 2.38% | 1.28% | -1.29% | -0.50% | 1.20% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.